1상모집 중단 (진행 중)
Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults
연구 개요
This clinical research trial will evaluate the safety and tolerability of an experimental drug, ALN-F1202, in healthy participants. The purpose of this trial is to learn about how safe and tolerable the experimental drug is. The trial is looking at several other research questions, including: * What side effects may happen from taking the experimental drug? * How much experimental drug is in the blood at different times? * Whether the body makes antibodies against the experimental drug (which could make the drug less effective or could lead to side effects). * What is the best dose of the experimental drug?
- 스폰서
- 리드: 리제네론
- 적응증
- Healthy Volunteer
- 중재
- ALN-F1202, Matching Placebo
- 목표 등록
- 56명
- 시작일
- 2025-03-06
- 완료(예정)
- 2026-07-30
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.